Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biohaven Pharmaceuticals
Biotech
‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections
“The stories are so outrageous,” Sen. Johnson told Bloomberg about recent FDA rebuffs. “It just appears that they’re looking for excuses to say no.”
Gabrielle Masson
Mar 10, 2026 11:10am
Biohaven reduces scope of R&D cuts as pipeline progresses
Mar 3, 2026 9:00am
How Biohaven is keeping its 'feet to the fire'
Feb 20, 2026 10:30am
Biohaven CEO calls recent FDA decisions 'a systemic problem'
Feb 13, 2026 4:14pm
2025's top 10 clinical trial flops
Feb 9, 2026 3:00am
Biohaven flunks depression trial, adding to CNS release concerns
Jan 2, 2026 4:48am
